Medical Device | Healthcare | Biotechnology | Pharmaceuticals

The global healthcare provider network management market is poised to reach USD 2.96 Billion by 2020, growing at a CAGR of 10.7% during the forecast period of 2015 to 2020. The growth of the overall market can be contributed to implementation of stringent federal mandates in the U.S., growing focus on improving quality of care through the effective use of payer reporting requirements. In the coming years, the global market is expected to witness the highest growth rate in North America region with emphasis on the U.S. North America is also expected to account for the largest share of the global healthcare provider network management market. The high growth in the North America can be attributed to the increase in health insurance coverage triggered by the Patient Protection and Affordable Act (PPACA) in the U.S., the rising need to curtail escalating healthcare costs in the U.S. and Canada, and the government focus on healthcare IT solutions in Canada. The report segments the globa

Europe is estimated to hold the largest share in ostomy care market in 2017 owing to the fact that European countries have a higher prevalence of IBD which is results in a higher number of ostomy surgeries. The unfavourable reimbursement scenarios in most of developing countries, and discomfort and other issues associated with the use of ostomy bags are expected to restrain the growth of ostomy care market . The global ostomy care market is expected to reach USD 2.99 Billion by 2022 from USD 2.28 Billion in 2016, at a CAGR of 4.5%. Get Crucial Industry Insights | Download PDF Brochure Now: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267183143 Ostomy Care Products Market: 1. Ostomy Care Bags 2. Ostomy Care Accessories The bags segment is further categorized into surgery type, system type, and usability. On the basis of surgery type, ostomy bags are segmented into – ileostomy, colostomy, and urostomy. On the basis of system type, the market is classified into on

Europe is the major revenue-generating regions in the global physiotherapy equipment market . Factors such as the rising geriatric population, increasing inclination for active lifestyles, the penetration of physiotherapy services, and favorable healthcare reforms are driving the growth of the physiotherapy equipment industry in Europe. Players in the physiotherapy equipment market are increasingly focusing on technological advancements and developing new products to bring out advanced and easy-to-use devices. Advancements such as virtual reality, robotics, exoskeletons, implanted devices, and interactive video games are expected to provide a wide range of opportunities for market players. The physiotherapy equipment market is projected to reach USD 21.1 billion by 2024 from USD 15.1 billion in 2018, at a CAGR of 5.8%. The growth of this market is primarily driven by rapidly growing geriatric population and the subsequent increase in the global prevalence of chronic diseases, an

Medtronic is the leading provider of digital diabetes management solutions across the globe. The company offers a portfolio of health information exchange solutions, clinical decision support solutions, and telehealth solutions and services to meet the needs of patients and physicians working in the areas of diabetes management. The company focuses on developing integrated devices that enable data sharing between devices, patients, care providers, and healthcare professionals to help generate actionable insights. Roche is one of the leading providers of blood glucose monitoring systems in the digital diabetes management market . The company offers digital glucometers, diabetes management applications, and data management software. To maintain its position in this market, the company focuses on expanding its product portfolio through organic and inorganic strategies, such as product launches, collaborations, partnerships, agreements, and acquisitions. The global digital diabete

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg

According to a new market research report  " Angiographic Catheters Market   by Application (Coronary, Endovascular, Neurology and Oncology), Geography ( North America ,  Europe ,  Asia Pacific  and Row), End-User Analysis (Reusage Scenario, Purchase Pattern) and Competitive Scenario - Global Forecast to 2022" , the global market is projected to reach  USD 1,402.8 Million  by 2022 from  USD 980.9 Million  in 2017, at a CAGR of 7.4%. The Angiographic Catheters Market is primarily driven by the rising incidence of coronary artery diseases across the globe. Further, increasing demand for angiographic catheters in various applications such as chemoembolization, awareness regarding various diseases such as CVDs, and preference for minimally invasive surgeries are also driving the growth of this market. Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1219487 Based on application, the coronary segment is projected to register the highest growt

According to a new market research report  " Q-TOF Mass Spectrometry Market   by Application (Biotech Applications, Pharmaceutical Applications, Food & Beverage Testing, Environmental Testing, Petrochemical Applications), and Region ( North America ,  Europe , APAC, and Row) - Global Forecast to 2022",  published by MarketsandMarkets™, the market is expected to reach  USD 1,009.7 million  by 2022 from an estimated  USD 698.4 million  in 2017, at a CAGR of 7.7%. Browse   46 market data Tables and   26 Figures spread through 103 Pages and in-depth TOC on   "Q-TOF Mass Spectrometry Market". The key factors that drive the market growth include technological advancements in Q-TOF Mass Spectrometry and stringent government regulations with respect to drug safety. The growing use of Q-TOF mass spectrometers in emerging markets is the key opportunity area, while the dearth of skilled professionals for such high-end instruments could be a challenging factor for the

What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report  "Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics) - Global Forecast to 2024" , published by MarketsandMarkets™, the market for Immuno-Oncology Assays is expected to grow from  USD 2.9 billion  in 2018 to  USD 5.9 billion  by 2024, at a CAGR of 12.7% during the forecast period. Don't miss out on business opportunities in  Immuno Oncology Assays Market . Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52562166 Key Players and Growth Strategies Adopted by Them: The key players

The global plastic surgery instruments market was valued at USD 937.3 Million in 2017 and is projected to reach USD 1,479.0 Million by 2023, at a CAGR of 8.1%. North America is expected to dominate the market followed by Europe. Asia is expected to grow at the highest CAGR during the forecast period. The high growth rate of the region is attributed to factors such as the growing middle-class disposable income in emerging Asian countries, growing aging population and age-related cosmetic procedures, and increasing medical tourism in the region. The increasing focus of prominent players in Asia is also supporting market growth in the region. Increasing awareness and demand for cosmetic surgeries, growing number of age-related surgeries across the globe, and increasing incidence of cancer are the key drivers of the global plastic surgery instruments market . The presence of stringent safety regulations for cosmetic procedures and the growing adoption of nonsurgical approaches and

The cell sorting market is expected to reach $247.4 Million by 2021 from $176.5 Million in 2016, at a CAGR of 7.0% between 2016 and 2021. Factors such as technological advancements in cell sorters, rising funding and investments for development of innovative cell sorting techniques, growing adoption of cell sorter techniques in research activities, and launch of specific reagents for specific applications are driving the growth of this market. This report covers the cell sorting market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the global market in 2016, followed by Europe and Asia-Pacific. The Asia-Pacific market is expected to register the highest CAGR during the forecast period. The high growth of this regional segment can be attributed to growing prevalence of diseases such as cancer and HIV/AIDS, increasing research initiatives, and expansion

The global downstream processing market is poised to reach $22.03 Billion by 2021 from $10.32 Billion in 2016, at a CAGR of 16.4%. The growth of this market is propelled by the increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry. Emerging markets such as Asia-Pacific provide new growth opportunities to players in the market. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Countries like China, Japan, India, and South Korea, are expected to drive the demand for downstream processing products in the coming years. Also, growth in these markets will be fueled by significant investments by key market players, increasing government support, developing R&D infrastructure, and growing expertise and academic excellence. North America is the world’s largest pharmaceutical market and a leader in biopharmaceutical research. North America (comprising the U.S. and Canada) accounted for